Accuracy and precision analysis for a biophotonic assay of C-reactive protein
Authors:
- 18 February 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 145 (7) , 2751-2757
Abstract
A multiplexed biophotonic assay platform has been developed using the localised particle plasmon in gold nanoparticles assembled in an array and functionalised for two assays: total IgG and C-reactive protein (CRP). A protein A/G (PAG) assay, calibrated with a NIST reference material, shows a maximum surface coverage of θmax = 7.13 ± 0.19 mRIU, equivalent to 1.5 ng mm−2 of F(ab)-presenting antibody. The CRP capture antibody has an equivalent surface binding density of θmax = 2.95 ± 0.41 mRIU indicating a 41% capture antibody availability. Free PAG binding to the functionalised anti-CRP surface shows that only 47 ± 3% of CRP capture antibodies are correctly presenting Fab regions for antigen capture. The accuracy and precision of the CRP sensor assay was assessed with 54 blood samples containing spiked CRP in the range 2–160 mg L−1. The mean accuracy was 0.42 mg L−1 with Confidence Interval (CI) at 95% from −14.7 to 13.8 mg L−1 and the precision had a Coefficient of Variation (CV) of 10.6% with 95% CI 0.9%–20.2%. These biophotonic platform performance metrics indicate a CRP assay with 2–160 mg L−1 dynamic range, performed in 8 minutes from 5 μL of whole blood without sample preparation.Keywords
This publication has 24 references indexed in Scilit:
- Measurement of the localised plasmon penetration depth for gold nanoparticles using a non-invasive bio-stacking methodPhysical Chemistry Chemical Physics, 2013
- Antibody orientation on biosensor surfaces: a minireviewThe Analyst, 2013
- Whole blood screening of antibodies using label-free nanoparticle biophotonic array platformBiosensors and Bioelectronics, 2012
- Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic reviewFamily Practice, 2011
- The safety implications of missed test results for hospitalised patients: a systematic review: Figure 1BMJ Quality & Safety, 2011
- Human serum albumin interference on plasmon-based immunokinetic assay for antibody screening in model blood seraAnalytical Biochemistry, 2010
- Quantitative label-free screening for antibodies using scattering biophotonic microarray imagingAnalytical Biochemistry, 2010
- Whole serum BSA antibody screening using a label-free biophotonic nanoparticle arrayAnalytical Biochemistry, 2009
- Label-free antibody–antigen binding detection by optical sensor array based on surface-synthesized gold nanoparticlesBiosensors and Bioelectronics, 2008
- Quantitative Methods for Spatially Resolved Adsorption/Desorption Measurements in Real Time by Surface Plasmon Resonance MicroscopyAnalytical Chemistry, 2004